东兴证券股份有限公司关于漱玉平民大药房连锁股份有限 本次培训得到了公司的积极配合，全体培训人员均进行了认真深入学习，通 过本次培训，被培训人员加强了关于创业板上市公司规范运作要求的认识，对相 关事项规定有了更加深刻的理解，本次培训达到了预期目标，取得了较好的效果。 公司 2025 年度持续督导现场培训报告 东兴证券股份有限公司（以下简称"保荐机构"或"东兴证券"）作为漱玉 平民大药房连锁股份有限公司（以下简称"漱玉平民"或"公司"）向不特定对 象发行可转换公司债券的保荐机构，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关规定的要求，对漱玉平民相关人员进行了 2025 年度 持续督导培训，现将培训情况报告如下： 一、本次培训基本情况 2025 年 12 月 26 日，东兴证券具体负责本次培训工作的胡杰畏先生在漱玉 平民会议室通过现场培训的方式对公司控股股东、实际控制人、部分董事和高级 管理人员、董事会办公室相关人员进行了沟通及培训。 二、本次培 ...

1、漱玉转债（债券代码：123172）转股期限为 2023 年 6 月 21 日至 2028 年 12 月 14 日，最新有效的转股价格为人民币 14.95 元/股。 2、2025 年第四季度，共有 1,180 张"漱玉转债"完成转股（票面金额共计 11.80 万元 人民币），合计转成 7,880 股"漱玉平民"股票（股票代码：301017）；截至 2025 年 12 月 31 日，合计共有 3,119 张"漱玉转债"完成转股（票面金额共计 31.19 万元人民币）， 合计转成 20,712 股"漱玉平民"股票（股票代码：301017）。 3、截至 2025 年第四季度末，漱玉平民大药房连锁股份有限公司（以下简称"公司"） 剩余可转换公司债券（以下简称"可转债"）为 7,996,881 张，剩余票面总金额为 79,968.81 万元人民币。 | | | 漱玉平民大药房连锁股份有限公司 关于 2025 年第四季度可转换公司债券转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示： 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上 ...

Market Overview - The pharmaceutical commercial sector experienced a slight decline of 0.0% on December 30, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3965.12, also down by 0.0%, while the Shenzhen Component Index rose by 0.49% to 13604.07 [1] Stock Performance - Notable gainers in the pharmaceutical sector included: - Yingte Group (000411) with a closing price of 13.23, up by 9.98% and a trading volume of 419,800 shares [1] - Yao Yigou (300937) at 35.65, up by 7.64% with 125,700 shares traded [1] - HeFu China (603122) at 26.00, up by 6.17% with a trading volume of 985,200 shares [1] - Conversely, Saily Medical (603716) saw a decline of 3.19% to a closing price of 20.95, with a trading volume of 123,200 shares [2] Capital Flow - The pharmaceutical commercial sector saw a net inflow of 258 million yuan from institutional investors, while retail investors contributed a net inflow of 54.61 million yuan [2] - Notable capital flows included: - HeFu China (603122) with a net inflow of 286 million yuan from institutional investors [3] - Yingte Group (000411) with a net inflow of 134 million yuan from institutional investors [3] - Yao Yigou (300937) with a net inflow of 16.36 million yuan from institutional investors [3]

Group 1 - The stock of Shuyu Pingmin has dropped over 18% [1] - Other companies such as Renmin Tongtai, Dajia Weikang, Yingte Group, and Yao Yigou have all seen declines of over 5% [1] - Additional companies including Huaren Health, Zhongyao Holdings, and Kaikai Industrial have also experienced declines [1]

Group 1 - The stock of Shuyupingmin experienced a significant decline of 17.91% in a single trading day, with a turnover rate of 19.80% and a total transaction value of 767 million yuan, indicating high volatility with an amplitude of 11.33% [2] - Institutional investors net sold 69.84 million yuan worth of shares, while the Shenzhen Stock Connect saw a net purchase of 24.86 million yuan, reflecting mixed investor sentiment [2] - The top five trading departments accounted for a total transaction value of 181 million yuan, with net selling amounting to 43.44 million yuan, highlighting a trend of selling pressure from institutional investors [2] Group 2 - As of December 26, the margin trading balance for the stock was 186 million yuan, with a financing balance of 185 million yuan and a securities lending balance of 40.81 thousand yuan, indicating a substantial increase in financing activity over the past five days [3] - The financing balance increased by 51.33 million yuan, representing a growth of 38.33%, while the securities lending balance saw a minor increase of 0.82 thousand yuan, or 2.04% [3] - The trading data on December 29 showed that the top buying department was the Shenzhen Stock Connect, with a purchase amount of 25.40 million yuan, while institutional selling was concentrated among several specialized seats [3][4]

Market Overview - The pharmaceutical commercial sector experienced a decline of 1.82% on December 29, with the leading stock being Shuyupingmin [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Stock Performance - Notable gainers included: - Denglushiyao (002788) with a closing price of 22.26, up 6.00% and a trading volume of 869,000 shares, totaling 1.863 billion yuan [1] - Saily Medical (603716) closed at 21.64, up 0.74% with a trading volume of 109,600 shares, totaling 237 million yuan [1] - Significant decliners included: - Shuyupingmin (301017) with a closing price of 15.58, down 17.91% and a trading volume of 481,800 shares, totaling 767 million yuan [2] - Renmintongtai (600829) closed at 11.17, down 6.84% with a trading volume of 367,700 shares, totaling 414 million yuan [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 804 million yuan from institutional investors, while retail investors experienced a net inflow of 892 million yuan [2] - The capital flow for specific stocks showed: - Nanjing Pharmaceutical (600713) had a net inflow of 11.27 million yuan from institutional investors [3] - Shanghai Pharmaceutical (601607) saw a net inflow of 8.81 million yuan from institutional investors [3] - Dajia Weikang (301126) had a net outflow of 406,000 yuan from institutional investors [3]

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-119 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于为全资及控股子公司开展融资租赁业务提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、担保情况概述 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 1 月 21 日召开第 四届董事会第三次会议，于 2025 年 2 月 6 日召开 2025 年第一次临时股东大会，审议通过 了《关于 2025 年度公司及子公司向银行等机构申请综合授信额度及提供担保的议案》，同 意公司及子公司 2025 年度对合并报表范围内各级子公司提供的担保额度为人民币 167,011.00 万元。公司于 2025 年 12 月 10 日召开第四届董事会第十四次会议，于 2025 年 12 月 26 日召开 2025 年第五次临时股东会审议通过了《关于追加 2025 年度担保额度的议案》， 该次追加担保额度后，公司及子公司为合并报表 ...

Market Overview - The A-share market experienced fluctuations, with the Shanghai Composite Index closing up 0.04% at 3965.28 points, marking a nine-day rise, while the Shenzhen Component Index fell 0.49% to 13537.1 points, and the ChiNext Index dropped 0.66% to 3222.61 points. The total trading volume in both markets reached 2.14 trillion yuan, with over 3300 stocks declining [1] Hot Sectors - The commercial aerospace sector continued to show strength, with over ten stocks hitting the daily limit, including Shenjian Co. with eight consecutive limit-ups. The recent announcement from the Shanghai Stock Exchange regarding new listing rules for commercial rockets is expected to drive demand in related industries such as satellite manufacturing and ground equipment [2] - The brain-computer interface sector saw significant gains, with stocks like Haige Communication and Xilinmen hitting the daily limit. This surge followed the opening of the Fifth Frontier Brain Science and Industry Conference, which launched the "Guangdong-Hong Kong-Macao Greater Bay Area Brain Science and Central Nervous System Disease AI Innovation Alliance" [3] - The carbon fiber sector experienced a rally, with stocks like Heshun Technology and Jilin Chemical Fiber hitting the daily limit. This was influenced by Toray's announcement of a price increase for its carbon fiber products, expected to improve market conditions [4] - The robotics sector remained active, with stocks such as Awat New Materials and Buke Co. hitting the daily limit and reaching historical highs. The establishment of a humanoid robot standardization committee is anticipated to drive growth in specialized robotics [5] Institutional Insights - CITIC Securities noted that a year-end market rally has begun, driven by optimistic expectations among institutional investors, improved overseas liquidity, and a series of policy announcements. Key sectors to watch include non-ferrous metals and AI computing power, with commercial aerospace remaining the primary focus [6] - Guosheng Securities suggested that the market is likely to confirm its direction before the holiday, despite ongoing adjustments. They highlighted the potential for a mid-term reversal in various sectors [8] - Huatai Securities indicated that while the overseas environment has improved, the A-share market may still experience volatility in the short term due to a lack of cohesive funding and ongoing policy uncertainties. They recommend focusing on sectors with improving fundamentals, such as batteries and certain chemicals [9]

（文章来源：每日经济新闻） 每经AI快讯，12月29日，医药商业股持续下挫，漱玉平民跌超18%，人民同泰、达嘉维康、英特集团、 药易购均跌逾5%，华人健康、重药控股、开开实业等跟跌。 ...

Group 1 - The pharmaceutical commercial sector experienced a decline at the beginning of trading, with notable drops in stock prices [1] - Shuyupingmin saw a decrease of over 15%, while Renmintongtai fell by more than 7% [1] - Other companies such as Huaren Health, Dajia Weikang, and Ruikang Pharmaceutical also followed the downward trend [1]